Endocare adds PSA test to urology workstation:
This article was originally published in Clinica
Endocare has signed a five-year agreement with privately owned Qualigen, to add its point-of-care total PSA test to Endocare's urology diagnostic workstation. The agreement offers one year of exclusivity with further renewals. The FDA-approved 15 minute test is the first of a series that will assist in Endocare's plan to become a total solutions provider for prostate and urological disease, the company claims.